Traci L. Kruer, Ariel Quintana, Hannah Newman, Meghan Ferrall-Fairbanks, Ling Zhang, Amy McLemore, Surendra Neupane, Qin Yang, Nana Adjoa Dankyi, Maria E. Balasis, Christopher Letson, Rami Komrokji, Sana Chaudhry, Tulasigeri M. Totiger, Joshua Traina, Maria E. Figueroa, Christopher B. Ryder, Thomas Cluzeau, Justin Taylor, David A. Sallman, Eric Padron. "XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53 -mutated myeloid malignancies." Blood, 2025. doi:10.1182/blood.2025028803